Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients

被引：8
|
作者：
Kuypers, D. R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
关键词：
D O I：
10.1038/clpt.2010.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：595 / 596
页数：2
相关论文
共 50 条
  • [1] Response to "Pharmacogenetic vs. Concentration-Controlled Optimization of Tacrolimus Dosing in Renal Allograft Recipients"
    Thervet, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 597 - 597
  • [2] A Comparative, Randomized Trial of Concentration-Controlled Sirolimus Combined With Reduced-Dose Tacrolimus or Standard-Dose Tacrolimus in Renal Allograft Recipients
    Bechstein, W. O.
    Paczek, L.
    Wramner, L.
    Squifflet, J. -P.
    Zygmunt, A. J.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2133 - 2140
  • [3] PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL-ALLOGRAFT RECIPIENTS - A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATION
    MUELLER, EA
    KOVARIK, JM
    VANBREE, JB
    LISON, AE
    KUTZ, K
    TRANSPLANTATION, 1994, 57 (08) : 1178 - 1182
  • [4] Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients
    Gong, Nianqiao
    Chen, Zhishui
    Wang, Jing
    Fang, Aifang
    Li, Yonghai
    Xiang, Ying
    Ming, Changsheng
    Zhang, Weijie
    CELLULAR IMMUNOLOGY, 2015, 297 (02) : 87 - 93
  • [5] Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
    Russ, GR
    Campbell, S
    Chadban, S
    Eris, J
    O'Connell, P
    Pussell, B
    Walker, R
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (3A) : 115S - 117S
  • [6] Concentration Controlled Mycophenolate and Tacrolimus Dosing in Renal Transplantation in India.
    Basu, G.
    Annapandian, V. M.
    Mathew, B. S.
    Saravanakumar, K.
    Mohapatra, A.
    David, V. G.
    Alexander, S.
    Varughese, S.
    Fleming, D. H.
    Tamilarasi, V.
    Jacob, C. K.
    John, G. T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 411 - 411
  • [7] Transition From Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Impact On Glycemic Parameters
    Diekmann, F.
    Tedesco-Silva, H.
    Peddi, V.
    Sanchez-Fructoso, A.
    Marder, B.
    Russ, G.
    Flynn, A.
    Hahn, C.
    Li, H.
    Tortorici, M.
    Schulman, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 540 - 541
  • [8] Pharmacogenetic-Based Warfarin Dosing: Simplified Pharmacogenetic Tables vs. Pharmacogenetic Algorithms
    Finkelman, Brian S.
    Gage, Brian F.
    Johnson, Julie A.
    Brensinger, Colleen M.
    Kimmel, Stephen E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S114 - S114
  • [9] Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations
    Zhang, Xiao
    Lin, Guigao
    Tan, Liming
    Li, Jinming
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 107 - 114
  • [10] Transition From Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Impact On Glycemic Parameters.
    Diekmann, F.
    Tedesco-Silva, H.
    Peddi, V.
    Sanchez-Fructoso, A.
    Marder, B.
    Russ, G.
    Flynn, A.
    Hahn, C.
    Li, H.
    Tortorici, M.
    Schulman, S.
    TRANSPLANTATION, 2014, 98 : 540 - 541
12345